Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Stock analysts at Wedbush upped their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research report issued to clients and investors on Monday, March 10th. Wedbush analyst D. Nierengarten now anticipates that the company will earn $0.55 per share for the year, up from their […]
